Chesworth Richard 4
4 · Kymera Therapeutics, Inc. · Filed Aug 21, 2020
Insider Transaction Report
Form 4
Chesworth Richard
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-08-20+351,119→ 351,119 totalExercise: $20.00Exp: 2030-08-19→ Common Stock (351,119 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on August 17, 2021, and the remainder of the shares shall vest in equal monthly installments for a period of thirty-six (36) months thereafter.